These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7396323)
1. [Aluminum gels in chronic kidney failrue patients. A potential risk of encephalopathy and osteopathy]. Rottembourg J; Jaudon MC; Legrain M; Galli A Ann Med Interne (Paris); 1980; 131(2):71-4. PubMed ID: 7396323 [No Abstract] [Full Text] [Related]
3. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure. Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766 [No Abstract] [Full Text] [Related]
5. [Bone and aluminum]. Wendling D; Guidet M Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):705-13. PubMed ID: 3103201 [No Abstract] [Full Text] [Related]
6. [Current concepts of the role of aluminum in chronic kidney failure patients]. Gruev I; Belovezhdov N Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201 [No Abstract] [Full Text] [Related]
7. Aluminum in tissues. Van de Vyver FL; De Broe ME Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959 [TBL] [Abstract][Full Text] [Related]
8. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy. Milne FJ; Sharf B; Bell P; Meyers AM Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027 [TBL] [Abstract][Full Text] [Related]
9. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease. Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691 [No Abstract] [Full Text] [Related]
10. [Aluminum-related bone disease in chronic hemodialysis patients]. Jara A; Rosenberg H; Bruhn C; Vaccarezza A; Vial S; Jalil R; Cisternas H Rev Med Chil; 1993 Jul; 121(7):769-76. PubMed ID: 8296081 [TBL] [Abstract][Full Text] [Related]
11. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy]. Matsubara M; Totsune K; Saito T; Yoshinaga K; Unagami H; Sato H Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516 [No Abstract] [Full Text] [Related]
12. Aluminum toxicity in patients with chronic renal failure. Alfrey AC Ther Drug Monit; 1993 Dec; 15(6):593-7. PubMed ID: 8122300 [TBL] [Abstract][Full Text] [Related]
14. Dialysis encephalopathy secondary to aluminum toxicity, diagnosed by bone biopsy. Andrade LG; Garcia FD; Silva VS; Gabriel DP; Rodrigues AG; Nascimento GV; Caramori JT; Martin LC; Barretti P; Balbi AL Nephrol Dial Transplant; 2005 Nov; 20(11):2581-2. PubMed ID: 16105866 [No Abstract] [Full Text] [Related]
15. [Aluminum osteopathy in a patient hemodialysed for chronic renal insufficiency and treated by long term administration of sucralfate]. Level C; de Precigout V; Larroumet N; Blanchetier V; Potaux L; Aparicio M Rev Med Interne; 1996; 17(4):348-9. PubMed ID: 8761804 [No Abstract] [Full Text] [Related]
16. Dialysis encephalopathy associated with polyvalent ion contamination. Hocken AG N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579 [TBL] [Abstract][Full Text] [Related]